Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

NTHIBullishIndustry Newsnews

High materiality8/10

NeOnc Phase 2a data readout could trigger a major NTHI repricing

Aug 11, 2026, 4:56 PM EDT2 sourcesAI-analyzed

Why it may matterVerify against the original reporting

A Likely binary readout (NEO100 Phase 2a) near a 52-week low, tight float, and notable shorts create a high-dispatch event risk-reward; positive data could trigger outsized repricing, while weak data may cause swift pullbacks.

AI summary

What happened, with direct paths to the underlying reporting

NeOnc's NEO100-01 Phase 2a topline data for IDH1-mutant glioma is the key catalyst. With the stock near a 52-week low and analyst targets up to $20, a data beat could trigger a sharp repricing. A tight float and about 0.52 million short interest could magnify moves, while the ATM remains unused.

NEO100-01 Phase 2a topline data due Aug 12; potential binary catalyst.
NTHI trades near 52-week low with potential valuation rerating on data.
Short interest ~521,841 shares; float size disputed across data providers.
Analysts' targets up to $20; average around $16 vs current price.
ATM $75M available but unused; funding largely via PIPEs.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.